Abstract
Thioetherhydroxyethylsulfonamide derivatives were synthesized and evaluated for their in vitro antibacterial activity against Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853) and Staphylococcus aureus (ATCC 25923). Results have shown that compounds 8c and 9e display potent activity (MIC = 0.125 µg/mL) against E. coli when compared with the standard drug sulfamethoxazole (SMZ, MIC < 0.5 µg/mL) for this same strain. All the new compounds were fully identified and characterized by NMR (1H and 13C) and X-ray crystallography (for compound 8c). This class of compounds can be considered as a good starting point for the development of new lead molecules in the fight against multi-drug bacterial resistance.
Keywords: Antibacterial, chemical biology, drugs, sulfonamides, thioetherhydroxyethylsulfonamides, X-Ray.
Medicinal Chemistry
Title:Antibacterial Activity of Thioetherhydroxyethylsulfonamide Derivatives
Volume: 10 Issue: 3
Author(s): Walcimar T. Vellasco Junior, Guilherme P. Guedes, Victor Facchinetti, Thatyana R.A. Vasconcelos, Maria G.F. Vaz, Wilson Cunico, Marcus V.N. de Souza, Geraldo R. de Paula, Maria E.C.K. Fleming and Claudia R.B. Gomes
Affiliation:
Keywords: Antibacterial, chemical biology, drugs, sulfonamides, thioetherhydroxyethylsulfonamides, X-Ray.
Abstract: Thioetherhydroxyethylsulfonamide derivatives were synthesized and evaluated for their in vitro antibacterial activity against Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853) and Staphylococcus aureus (ATCC 25923). Results have shown that compounds 8c and 9e display potent activity (MIC = 0.125 µg/mL) against E. coli when compared with the standard drug sulfamethoxazole (SMZ, MIC < 0.5 µg/mL) for this same strain. All the new compounds were fully identified and characterized by NMR (1H and 13C) and X-ray crystallography (for compound 8c). This class of compounds can be considered as a good starting point for the development of new lead molecules in the fight against multi-drug bacterial resistance.
Export Options
About this article
Cite this article as:
Vellasco Junior T. Walcimar, Guedes P. Guilherme, Facchinetti Victor, Vasconcelos R.A. Thatyana, Vaz G.F. Maria, Cunico Wilson, de Souza V.N. Marcus, de Paula R. Geraldo, Fleming E.C.K. Maria and Gomes R.B. Claudia, Antibacterial Activity of Thioetherhydroxyethylsulfonamide Derivatives, Medicinal Chemistry 2014; 10 (3) . https://dx.doi.org/10.2174/1573406410666140218103022
DOI https://dx.doi.org/10.2174/1573406410666140218103022 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
NRF2-Dependent Glutamate-L-Cysteine Ligase Catalytic Subunit Expression Mediates Insulin Protection Against Hyperglycemia-Induced Brain Endothelial Cell Apoptosis
Current Neurovascular Research Anti-Inflammatory and Antioxidant Properties of a New Arylidene-Thiazolidinedione in Macrophages
Current Medicinal Chemistry Protecting the Heart: Biological Targets and Clinical Strategies
Current Pharmaceutical Design Impact of Oral 1,25-Dihydroxy Vitamin D (Calcitriol) Replacement Therapy on Coronary Artery Risk Factors in Type 2 Diabetic Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Drug Delivery Systems for the Treatment of Diabetes Mellitus: State of the Art
Current Pharmaceutical Design Editorial (Thematic Issue: Is The Female Heart Exposed To Cardiovascular Disease?)
Current Medicinal Chemistry The GH/IGF-1 Axis and Heart Failure
Current Cardiology Reviews Inflammation, Sleep, Obesity and Cardiovascular Disease.
Current Vascular Pharmacology Can PPARγ Ligands Be Used in Cancer Therapy?
Current Medicinal Chemistry - Anti-Cancer Agents Nanocarriers and their Actions to Improve Skin Permeability and Transdermal Drug Delivery
Current Pharmaceutical Design Oxytocin as a Potential Adjuvant Against COVID-19 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets Can Untargeted Metabolomics Be Utilized in Drug Discovery/Development?
Current Topics in Medicinal Chemistry Pharmacokinetics and Tissue Distribution of Fargesin After Oral Administration in Rats by High Performance Liquid Chromatography
Current Pharmaceutical Analysis Functional aspects in ageing adults with diabetic neuropathy. A review.
Current Diabetes Reviews Voglibose (Basen®, AO-128), One of the Most Important α-Glucosidase Inhibitors
Current Medicinal Chemistry The ErbB Receptors and Their Ligands in PKD, an Overview
Current Signal Transduction Therapy Standardization of Epitopes for Human Chorionic Gonadotropin (hCG) Immunoassays
Current Medicinal Chemistry Arterial Stiffness: A Novel Cardiovascular Risk Factor in Kidney Disease Patients
Current Vascular Pharmacology Glibenclamide Action on Myocardial Function and Arrhythmia Incidence in the Healthy and Diabetic Heart
Cardiovascular & Hematological Agents in Medicinal Chemistry Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
Current Cancer Drug Targets